All In Biotech

Free tool

FAERS Monitor: Atacand

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020838 or its brand name (Atacand, Candesartan Cilexetil). Reports on generic versions are filed under their own applications.

Reports

26,474

Serious

23,278

88% of reports

Hospitalization

12,870

Death reported

2,476

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,752
  • fatigue1,751
  • nausea1,666
  • headache1,637
  • drug ineffective1,623
  • dizziness1,519
  • diarrhoea1,389
  • malaise1,380
  • off label use1,330
  • fall1,296
  • pain1,249
  • vomiting1,164
  • hypertension1,160
  • blood pressure increased1,156
  • asthenia1,096

Reports by year received

View as table
YearReports
2004461
2005543
2006609
2007853
2008909
20091,077
20101,382
20112,050
20122,398
20131,086
2014988
2015977
2016843
2017815
20181,332
20191,424
20201,455
20211,261
20221,313
20231,225
20241,243
20251,195
20261,034

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,685 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure increasedSignal1,1566.05.74,861
hypertensionSignal1,1604.44.13,025
fallSignal1,2963.12.91,866
malaiseSignal1,3802.52.41,268
dyspnoeaSignal1,7522.52.41,559
dizzinessSignal1,5192.42.31,296
astheniaSignal1,0962.32.2834
headacheSignal1,6372.12.0939
vomiting1,1642.01.9566
fatigue1,7511.81.7630
diarrhoea1,3891.71.6422
nausea1,6661.71.6468
pain1,2491.61.5301
off label use1,3301.21.149
drug ineffective1,6231.00.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.